Endocrine

January 2015 Vol. 10 No 1

Author: Preventing adverse outcomes may hinge on your ability to identify and overcome barriers that prevent some pregnant women from managing their diabetes properly.

According to the Centers for Disease Control and Prevention (CDC), 9.2% of pregnant women develop gestational diabetes mellitus (GDM) as a serious complication during pregnancy. A positive glucose tolerance test in the second trimester can be a shock for an expectant woman.

Poor glucose control can lead to poor . . .

December 2014 Vol. 9 No. 12

Author: Stacey A. Seggelke, MS, RN, CNS, CDE, BC-ADM

Continuing Nursing Education
Learning objectives 1. Differentiate between enteral and parenteral nutrition. 2. Discuss how to manage hypoglycemia and hyperglycemia in patients with diabetes who are receiving supplemental nutrition. 3. Describe insulin use in patients with diabetes who are receiving supplemental nutrition. Purpose/goal: To provide nurses with information on . . .

September 2014 Vol. 9 No. 9

Author: Julie S. Lampe, MSN, CNS, CNS-BC, ADM-BC

It’s lunchtime. Three of your patients are scheduled to receive rapid-acting insulin in addition to sliding-scale insulin.

Mr. Jones, age 87, has type 2 diabetes. His blood glucose level is 223 mg/dL. He’s on a clear diet.
Mrs. Smith, age 63, has type 1 diabetes . . .

August 2014 Vol. 9 No. 8

Author: Stacey A. Seggelke, MS, RN, ACNS-BC, BC-ADM, CDE

Approximately 25.8 million children and adults in the United States have diabetes. Especially with the diabetes rate rising yearly, you’re likely to care for many patients with this disorder.

Of those diagnosed with diabetes, 80% take diabetes medication (oral drugs, insulin, or both). Hypoglycemia is one of the . . .

August 2014 Vol. 9 No. 8

On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Read more . . .

July 2014 Vol. 9 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Read more . . .

July 2014 Vol. 9 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

In patients with a traumatic brain injury (TBI), the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin (Hgb) concentration through blood transfusion did not improve neurological outcome at 6 months, according to a study in JAMA. Transfusing at higher hemoglobin concentrations was associated with a higher risk . . .

June 2014 Vol. 9 No. 6

Author: Cindy Lefton, PhD, RN

On June 6, the U.S. Food and Drug Administration (FDA) approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Read more . . .

June 2014 Vol. 9 No. 6

Author: Cindy Lefton, PhD, RN

At least 10 percent of people who have a myocardial infarction (MI) may have undiagnosed diabetes, according to research presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2014. Read more . . .

May 2014 Vol. 9 No. 5

Author: David Foley, MSN, RN, MPA

A Phase II study found that patients with ACE inhibitor-induced angioedema who received ecallantide were more likely to be discharged sooner than those treated with antihistamines and steroids. Read more . . .

April 2014 Vol. 9 No. 4

Author: Miriam O. Young, MSN, RN

Oligomeric procyanidins (PCs), a type of flavanol in chocolate, could help reduce obesity, according to a study in Journal of Agricultural & Food Chemistry. Adding PCs to the food of mice that ate a high-fat diet, keep them from gaining excess weight and improved glucose tolerance. Read more and . . .